Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oscar HealthMIL:1OSCR 60 EV-to-EBIT is 9.96 as of Aug. 25, 2026, which is 4643% above its 10-year median of 0.21. GuruFocus rates MIL:1OSCR with a GF Score™ of 60/100 and a GF Value™ of €18.63 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 15 Healthcare Plans companies, Oscar Health ranks better than 73.33% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Oscar Health's Enterprise Value for the quarter that ended in Jun. 2026 was €4,628 Mil.
Oscar Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €531 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health EV-to-EBIT Related Terms
Oscar Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Oscar Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1OSCR vs MOH, ALHC, PGNY: EV-to-EBIT Comparison
For the Healthcare Plans subindustry, Oscar Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oscar Health EV-to-EBIT vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Oscar Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Oscar Health's EV-to-EBIT falls into.
Oscar Health's current Enterprise Value is €5,288 Mil.
Oscar Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €531 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health (MIL:1OSCR) has a EV-to-EBIT of 9.96 as of Aug. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Oscar Health and its competitors. This is 4643% above median its historical median of 0.21. According to the industry distribution chart, Oscar Health ranks #4 out of 15 companies in the Healthcare Plans industry, placing it in the top 26.7%.
Is Oscar Health's EV-to-EBIT too high?
Oscar Health's current EV-to-EBIT of 9.96 is 4643% above median its 10-year median of 0.21. The Healthcare Plans industry median EV-to-EBIT is 19.09. Oscar Health's value of 9.96 is 47.8% below this industry median. Based on the distribution chart, Oscar Health ranks #4 out of 15 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Oscar Health has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's EV-to-EBIT compare to MOH and ALHC?
According to the Healthcare Plans industry distribution chart, Oscar Health ranks #4 out of 15 companies for EV-to-EBIT. This puts Oscar Health in the upper half of its industry. The industry median EV-to-EBIT is 19.09. Oscar Health's value of 9.96 is 47.8% below this benchmark. While the company's 10-year median is 0.21 vs. the industry median of 19.09, Oscar Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Plans company?
The median EV-to-EBIT among Healthcare Plans companies is 19.09, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oscar Health's current EV-to-EBIT of 9.96 is 47.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Oscar Health and its competitors. For the Healthcare Plans industry, the median EV-to-EBIT is 19.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oscar Health's current EV-to-EBIT is 9.96, which is 4643% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (MIL:1OSCR) is currently considered Significantly Overvalued. The stock's GF Value™ is €18.63, compared to a current price of €24.80 — trading 33.1% above its estimated fair value. The current EV-to-EBIT is 9.96, which is 4643% above median its 10-year median of 0.21 and 47.8% below the Healthcare Plans industry median of 19.09. Oscar Health's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Oscar Health (MIL:1OSCR), the current EV-to-EBIT is 9.96 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oscar Health (MIL:1OSCR) Overvalued in 2026?
Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued.
The current stock price of €24.80 is trading 33.1% above its estimated GF Value™ of €18.63.
GuruFocus considers Oscar Health to be Significantly Overvalued.
Key valuation signals for MIL:1OSCR:
EV-to-EBIT: 9.96 (4643% above median its 10-year median of 0.21)
GF Value™: €18.63 vs. price of €24.80 (33.1% above fair value)
Industry Position: 47.8% below the Healthcare Plans median (#4 of 15)
No single metric tells the full story. See the MIL:1OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
60GF Score
Get the complete analysis for MIL:1OSCR
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1OSCR has been successfully added to your 
